ESG

Promising data for NuCana's NUC-7738 offers hope for tough-to-treat melanoma, but the biotech's financial health presents a critical hurdle.

Beyond the hype, additive manufacturing is now a force in the skies. Discover how Stratasys and Airbus are using it to build lighter, greener, faster jets.

Behind EVs, AI, and medical breakthroughs lies a hidden process. Discover how ion implantation shapes the chips that power our future and our trust in it.

India's new Labour Code 2025 is forcing a strategic pivot. Discover how firms are turning regulatory mandates into a competitive edge for productivity.

As drone attacks paralyze European airports, an Israeli tech firm's 'soft kill' net system emerges as a key contender for NATO's defense strategy.

Beyond a simple payout, Amerigo Resources’ latest dividend reveals a powerful strategy of innovation, financial discipline, and a bullish copper market.

As holiday travel chaos looms, one luggage brand is offering free bags to travelers with lost luggage. Is it a marketing masterstroke or a logistical nightmare?

A Canadian youth sports leader's entry into India reveals a blueprint for AI-driven physical literacy and a new paradigm for children's healthcare.

Herbalife's new podcast with Paralympian Palak Kohli reveals a deeper trend: how corporate content is fueling a new ecosystem for para-athletes in India.

Chemical giant Nouryon is doubling down on Brazil, building a new innovation hub to co-create sustainable beauty and cleaning products for a booming market.

Providence Care's new CEO is a former therapist. Can his clinical insight solve market challenges and deliver on a private equity growth plan?

Capital Power unveils a $3B deal with Apollo to buy U.S. gas plants while securing a major deal to power Alberta's AI boom, a bold dual strategy.

A Texas battery plant is online in record time thanks to a Chinese robotics firm. Discover the 'factory in a box' strategy transforming industrial deployment.

Husqvarna unveils a massive cost-cutting plan alongside ambitious growth and green targets. Can this strategic pivot secure its future market leadership?

Hexagon Purus erases a $12.9M debt in its Panasonic battery deal but gives up lucrative US tax credits, a move securing its supply chain at a high cost.

A Chinese biotech is pioneering next-gen cancer drugs that promise higher precision and fewer side effects. Is this the future of oncology treatment?

Denali Therapeutics raises $200M to advance its brain-penetrating drugs, betting big on its pipeline despite short-term market jitters.

Following stellar clinical data, Terns Pharmaceuticals' upsized $650M offering signals massive investor confidence and funds its push to disrupt the CML market.

Major hotel chains are now building integrated living ecosystems for digital nomads. What does this pivot to wellness mean for the future of care?

Gossamer Bio's recent 200,000-share grant to a new hire is more than a welcome bonus; it's a strategic bet on its blockbuster drug candidate.